Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration

American Journal of Ophthalmology

Volumn 140, Issue 1, 2005, Pages 23.e1-23.e7

  Salinas Alamán, Angel ^a   García Layana, Alfredo ^a   Maldonado, Miguel J ^a   Sainz Gómez, Carmen ^a   Alvárez Vidal, Aurora ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN SODIUM;

AGED; AQUEOUS HUMOR; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DIAGNOSTIC ACCURACY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; THICKNESS;

EID: 22444440577     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2005.01.044     Document Type: Article

References (24)

1. R. Klein, B.E. Klein, K.L. Linton Prevalence of age-related maculopathy the Beaver Dam Eye Study Ophthalmology 99 1992 933 943
2. J.R. Vingerling, I. Dielemans, A. Hofman The prevalence of age-related maculopathy in the Rotterdam Study Ophthalmology 102 1995 205 210
3. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials-TAP report 1 Arch Ophthalmol 117 1999 1329 1345
4. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two year results of 2 randomized clinical trials-TAP report 2 Arch Ophthalmol 119 2001 198 207
5. Verteporfin in Photodynamic Therapy Study Group Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2 Am J Ophthalmol 131 2001 541 560
6. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) and Verteporfin in Photodynamic Therapy (VIP) Study Groups Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin. Fluorescein angiographic guidelines for evaluation and treatment-TAP and VIP Report No. 2 Arch Ophthalmol 121 2003 1253 1268
7. D. Huang, E.A. Swanson, C.P. Lin Optical coherence tomography Science 254 1991 1178 1181
8. H. Sánchez-Tocino, A. Álvarez-Vidal, M.J. Maldonado Retinal thickness study with optical coherence tomography in patients with diabetes Invest Ophthalmol Vis Sci 43 5 2002 1588 1594
9. M.R. Hee, C.A. Puliafito, C. Wong Quantitative assessment of macular edema with optical coherence tomography Arch Ophthalmol 113 1995 1019 1029
10. C.A. Puliafito, M.R. Hee, C.P. Lin Imaging of macular disease with optical coherence tomography Ophthalmology 102 1995 217 229
11. A.H. Rogers, A. Martidis, P.B. Greenberg Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization Am J Ophthalmol 134 4 2002 566 576
12. M.R. Hee, C.R. Baumal, C.A. Puliafito Optical coherence tomography of age-related macular degeneration and choroidal neovascularization Ophthalmology 103 1996 1260 1270
13. R.A. Costa, M.E. Farah, J.A. Cardillo Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization Retina 23 2003 159 165
14. U. Schmidt-Erfurth, S. Michels, I. Barbazetto Photodynamic effects on choroidal neovascularization and physiological choroid Invest Ophthalmol Vis Sci 43 3 2002 830 841
15. U.E.K. Schnurrbusch, K. Welt, L.C. Horn, P. Wiedemann, S. Wolf Histological findings of surgical excised choroidal neovascular membranes after photodynamic therapy Br J Ophthalmol 85 2001 1086 1091
16. D.M. Moshfeghi, P.K. Kaiser, H.E. Grossniklaus Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy Am J Ophthalmol 135 2003 343 350
17. K.J. Blinder, S. Bradley, N.M. Bressler Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration TAP and VIP report no. 1 Am J Ophthalmol 136 2003 407 418
18. F.G. Holz, J. Jorzik, F. Schutt Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-Study) Ophthalmology 110 2003 400 405
19. R.S. Kaiser, J.W. Berger, G.A. Williams Variability in fluorescein angiography interpretation for photodynamic therapy in age-related macular degeneration Retina 22 2002 683 690
20. S.M. Friedman, C.E. Margo Choroidal neovascular membranes reproducibility of angiographic interpretation Am J Ophthalmol 130 2000 839 841
21. R.J. Antcliff, M.R. Stanford, D.S. Chauhan Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis Ophthalmology 107 2000 593 599
22. A.E. Schneeberg, W. Gobel Diagnosis and follow-up of non-diabetic macular edema with optical coherence tomography Ophthalmologe 100 2003 960 966
23. S.W. Kang, C.Y. Park, D.I. Ham The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema Am J Ophthalmol 137 2004 313 322
24. L.A. Yannuzzi, K.T. Rohrer, L.J. Tindel Fluorescein angiography complication survey Ophthalmology 93 1986 611 617